HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Marc Simard Selected Research

J Marc Simard Research Topics

Disease

34Brain Edema (Cerebral Edema)
01/2022 - 04/2006
33Edema (Dropsy)
01/2022 - 01/2004
27Stroke (Strokes)
10/2022 - 01/2003
20Traumatic Brain Injuries (Traumatic Brain Injury)
06/2021 - 02/2008
19Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2021 - 02/2009
18Hemorrhage
01/2022 - 12/2008
17Ischemia
01/2020 - 01/2004
16Infarction (Infarctions)
01/2022 - 04/2006
15Ischemic Stroke
10/2019 - 12/2002
13Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 08/2007
12Wounds and Injuries (Trauma)
01/2021 - 02/2008
12Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2011
9Brain Injuries (Brain Injury)
07/2022 - 06/2003
9Neuroinflammatory Diseases
01/2021 - 07/2012
8Necrosis
02/2022 - 08/2007
8Hypoxia (Hypoxemia)
05/2015 - 01/2004
7Inflammation (Inflammations)
01/2022 - 02/2009
6Hypertension (High Blood Pressure)
12/2013 - 01/2003
5Pain (Aches)
07/2022 - 01/2019
5Spinal Injuries (Spinal Injury)
01/2021 - 01/2017
5Brain Contusion
01/2020 - 12/2009
5Contusions
01/2020 - 02/2012
4Hypothermia
06/2022 - 11/2015
4Cerebral Infarction
01/2021 - 01/2011
4Neoplasms (Cancer)
01/2018 - 11/2005
4Brain Neoplasms (Brain Tumor)
12/2017 - 10/2013
4Brain Diseases (Brain Disorder)
05/2015 - 12/2011
3Aneurysm (Aneurysms)
10/2019 - 12/2013
3Heart Arrest (Cardiac Arrest)
01/2018 - 10/2011
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 10/2013
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2015 - 02/2009
2Headache (Headaches)
07/2022 - 12/2021
2COVID-19
02/2022 - 01/2022
2Cytokine Release Syndrome
02/2022 - 01/2022
2Acute Pain
12/2021 - 11/2021
2Neurocognitive Disorders (Clerambault Syndrome)
10/2021 - 01/2021
2Neuralgia (Stump Neuralgia)
01/2021 - 01/2019
2Thrombocytopenia (Thrombopenia)
01/2021 - 12/2013
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 12/2013
2Gliosis
01/2021 - 09/2017
2Hydrocephalus (Hydrocephaly)
01/2020 - 08/2017
2Intracranial Hypertension
01/2019 - 10/2015
2Glioma (Gliomas)
01/2018 - 01/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2017 - 11/2015
2Hemorrhagic Stroke
03/2015 - 10/2013
2Craniocerebral Trauma (Head Injury)
12/2009 - 05/2009

Drug/Important Bio-Agent (IBA)

46Glyburide (Glibenclamide)FDA LinkGeneric
01/2022 - 04/2006
26Sulfonylurea ReceptorsIBA
12/2020 - 04/2006
21Adenosine Triphosphate (ATP)IBA
01/2019 - 01/2004
17Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2006
9Pharmaceutical PreparationsIBA
10/2022 - 12/2013
8Heparin (Liquaemin)FDA LinkGeneric
01/2021 - 12/2010
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 02/2009
6CationsIBA
08/2015 - 01/2004
5Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2006
5Ion Channels (Ion Channel)IBA
01/2020 - 08/2009
4CytokinesIBA
02/2022 - 01/2020
4Explosive Agents (Explosives)IBA
08/2019 - 10/2011
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2018 - 09/2012
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 09/2012
4Immunoglobulin G (IgG)IBA
08/2015 - 02/2009
3Opioid Analgesics (Opioids)IBA
07/2022 - 11/2021
3Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2021
3Aquaporins (Water Channels)IBA
11/2021 - 02/2015
3Toll-Like Receptor 4IBA
12/2020 - 03/2015
3OligodeoxyribonucleotidesIBA
01/2020 - 04/2010
3Biological ProductsIBA
12/2019 - 11/2005
3Caspase 3 (Caspase-3)IBA
07/2012 - 02/2009
3Angiotensin IIIBA
01/2006 - 01/2003
2Betulinic AcidIBA
10/2022 - 01/2019
2AntioxidantsIBA
10/2022 - 01/2019
2Analgesics (Analgesic Drugs)IBA
07/2022 - 11/2021
2NF-kappa B (NF-kB)IBA
02/2022 - 07/2012
2HMGB1 Protein (HMG1)IBA
01/2022 - 01/2020
2ChemokinesIBA
01/2022 - 01/2021
26,7-dihydroxyflavoneIBA
10/2021 - 01/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2021 - 09/2017
2LigandsIBA
01/2020 - 03/2015
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2020 - 01/2016
2Transient Receptor Potential ChannelsIBA
01/2019 - 08/2007
2Glial Fibrillary Acidic ProteinIBA
01/2019 - 10/2008
2ElementsIBA
10/2018 - 04/2014
2Nitric Oxide Synthase (NO Synthase)IBA
09/2017 - 01/2016
2RiluzoleFDA LinkGeneric
11/2015 - 01/2012
2SodiumIBA
04/2014 - 01/2012
2CalciumIBA
01/2013 - 08/2007
2PotassiumIBA
01/2013 - 01/2007
2fluoro-jade CIBA
07/2012 - 10/2011
2AngiotensinsIBA
10/2003 - 05/2003
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
05/2003 - 01/2003

Therapy/Procedure

19Therapeutics
07/2022 - 12/2010
10Decompressive Craniectomy
01/2022 - 05/2009
6Decompression
01/2021 - 01/2013
4Craniotomy
11/2021 - 12/2009
3Drug Therapy (Chemotherapy)
07/2022 - 01/2016
3Surgical Decompression
01/2019 - 09/2012
3Cardiopulmonary Resuscitation (CPR)
01/2018 - 10/2011
2Intravenous Administration
10/2022 - 01/2019
2Minimally Invasive Surgical Procedures
09/2019 - 02/2016
2Artificial Respiration (Mechanical Ventilation)
05/2015 - 12/2011